Skip to main content
ImmuneCited

Andrographis Şekiller

49 hakemli araştırmalardan görseller

Tümü Vitamin D Zinc Iron Andrographis Astragalus Elderberry Pelargonium sidoides Cordyceps Arginine N-Acetylcysteine Quercetin Curcumin Glutathione Resveratrol Astaxanthin Omega-3 Fatty Acids (EPA/DHA) Conjugated Linoleic Acid
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 18
Figure 18 Chart

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 19
Figure 19 Chart

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 20
Figure 20 Chart

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 21
Figure 21 Chart

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 22
Figure 22 Chart

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 23
Figure 23 Chart

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 24
Figure 24 Chart

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 25
Figure 25 Chart

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 26
Figure 26 Chart

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 27
Figure 27 Chart

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 28
Figure 28 Chart

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 29
Figure 29 Chart

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 30
Figure 30 Chart

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 31
Figure 31 Chart

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 32
Figure 32 Chart

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 33
Figure 33 Chart

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 34
Figure 34 Chart

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 35
Figure 35 Chart

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 36
Figure 36 Chart

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 37
Figure 37 Chart

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 38
Figure 38 Chart

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 39
Figure 39 Chart

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 40
Figure 40 Chart

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Figure 41
Figure 41 Chart

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …

Sayfa 2 / 3